Optimization of light source parameters in the photodynamic therapy of heterogeneous prostate

Physics in Medicine and Biology

Volumn 53, Issue 15, 2008, Pages 4107-4121

  Li, Jun ^a   Altschuler, Martin D ^a   Hahn, Stephen M ^a   Zhu, Timothy C ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOTHERAPY; CONCENTRATION (PROCESS); DATA ACQUISITION; DRUG DELIVERY; DRUG DOSAGE; DRUG THERAPY; INVERSE PROBLEMS; LIGHT SOURCES; LIGHTING; OPTICAL MATERIALS; OPTICAL PROPERTIES; OPTIMIZATION; PARAMETER ESTIMATION; PHOTODYNAMIC THERAPY; PLASMONS; RAY TRACING; SEMICONDUCTING CADMIUM TELLURIDE; THREE DIMENSIONAL;

CALCULATION TIME; CLINICAL USES; COMPUTATIONAL PROCEDURES; DOSE DISTRIBUTIONS; DRUG CONCENTRATIONS; EQUAL STRENGTH; FLUENCE; HETEROGENEOUS DATA; HETEROGENEOUS DISTRIBUTIONS; HETEROGENEOUS MEDIUM; IN-VIVO; KERNEL SIZE; MEAN VALUE; OPTICAL DATA; OPTIMAL DOSE; OPTIMIZATION PROCESSES; PHOTODYNAMIC THERAPY (PDT); S OURCE PARAMETERS; SIMPLER ALGORITHMS; THREE DIMENSIONAL (3D); TIME CONSTRAINTS; TREATMENT PLANNING;

LIGHT;

ALGORITHM; ARTICLE; CALCULATION; INFORMATION PROCESSING; KERNEL METHOD; LIGHT; LIGHT SCATTERING; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; PROSTATE; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; TREATMENT PLANNING;

HUMANS; LIGHT; MALE; PHOTOCHEMOTHERAPY; PROSTATE; THERAPY, COMPUTER-ASSISTED; TIME FACTORS;

EID: 48349126600     PISSN: 00319155     EISSN: 13616560     Source Type: Journal    
DOI: 10.1088/0031-9155/53/15/007     Document Type: Article

References (26)

1. Altschuler M D, Zhu T C, Li J and Hahn S M 2005 Optimized interstitial PDT prostate treatment planning with the Cimmino feasibility algorithm Med. Phys. 32 3524-36
2. Benzi M 2004 Gianfranco Cimmino's contributions to numerical mathematics Technical Report TR-2004-031-A Department of Mathematics and Computer Science, Emory University
3. Censor Y, Altschuler M D and Powlis W 1988 On the use of Cimmino's simultaneous projections method for computing a solution of the inverse problem in radiation therapy treatment planning Inverse Problems 4 607-23
4. Censor Y, Goron D and Gordon R 2001 Component averaging: an efficient iterative parallel algorithm for large and sparse unstructured problems Parallel Comput. 27 777-808
5. Chang S C, Buonaccorsi G, MacRobert A and Bown S G 1996 Interstitial and transurethral photodynamic therapy of the canine prostate using meso-tetra-(m-hydroxyphenyl) chlorin Int. J. Cancer 67 555-62
6. Chang S C, Buonaccorsi G, MacRobert A and Bown S G 1997 Interstitial photodynamic therapy of the canine prostate with disulfonated aluminum phthalocyanine and 5-aminolevulinic acid-induced protoporphyrin IX Prostate 32 89-98
7. Chen Q, Wilson B C, Shetty S D, Patterson M S, Cerny J C and Hetzel F W 1997 Changes in vivo optical properties and light distributions in normal canine prostate during photodynamic therapy Radiat. Res. 147 86-91
8. D'Amico A V 1996 Role of interstitial radiotherapy in the management of clinically organ-confined prostate cancer: the jury is still out J. Clin. Oncol. 14 304-15
9. De Pierro A R and Iusem A N 1985 A simultaneous projections method for linear inequalities Linear Algebra Appl. 64 243-53
10. Dougherty T J, Gomer C J, Henderson B W, Jori G, Kessel D, Korbelik M, Moan J and Peng Q 1998 Photodynamic therapy J. Natl Cancer Inst. 90 889-905
11. Du K L et al 2006 Preliminary results of interstitial motexafin lutetium-mediated PDT for prostate cancer Lasers Surg. Med. 38 427-34
12. Hsi R A, Kapatkin A, Strandberg J, Zhu T, Vulcan T, Solonenko M, Rodriguez C, Chang J, Saunders M, Mason N and Hahn S 2001 Photodynamic therapy in the canine prostate using motexafin lutetium Clin. Cancer Res. 7 651-60
13. Hsi R A, Rosenthal D I and Glatstein E 1999 Photodynamic therapy in the treatment of cancer: current state of the art Drugs 57 725-34
14. Jacques S L 1998 Light distributions from point, line and plane sources for photochemical reactions and fluorescence in turbid biological tissues Photochem. Photobiol. 67 23-32
15. Lee L K, Whitehurst C, Chen Q, Pantelides M L, Hetzel F W and Moore J V 1997 Interstitial photodynamic therapy in the canine prostate Br. J. Urol. 80 898-902
16. Li J and Zhu T C 2007 Modeling light-fluence rate distribution in optically heterogeneous prostate photodynamic therapy using a kernel method Proc. SPIE 6427 64270N
17. Li J and Zhu T C 2008 Determination of in vivo light-fluence distribution in heterogeneous prostate during photodynamic therapy Phys. Med. Biol. 53 2103-14
18. Li J, Zhu T C and Finlay J C 2006 Study of light-fluence rate distribution in photodynamic therapy using finite-element method Proc. SPIE 6139 61390M
19. Nakai T, Nishimura G, Yamamoto K and Tamura M 1997 Expression of optical diffusion coefficient in high-absorption turbid media Phys. Med. Biol. 42 2541-9
20. Powlis W D, Altschuler M D, Censor Y and Buhle E L Jr 1989 Semi-automated radiotherapy treatment planning with a mathematical model to satisfy treatment goals Int. J. Radiat. Oncol. Biol. Phys. 16 271-6
21. Schweiger M, Arridge S R, Hiraoka M and Delpy D T 1995 The finite element method for the propagation of light in scattering media: Boundary and source conditions Med. Phys. 22 1779-92
22. Stripp D C et al 2004 Phase I trial of motexafin-lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer Proc. SPIE 5315 88-99
23. Verigos K et al 2006 Updated results of a phase I trial of motexafin lutetium-mediated interstitial photodynamic therapy in patients with locally recurrent prostate cancer J. Environmental Pathol. Toxicol. Oncol. 25 373-87
24. Zhu T C et al 2005a Optical properties of human prostate at 732 nm measured in vivo during motexafin lutetium-mediated photodynamic therapy Photochem. Photobiol. 81 96-105
25. Zhu T C, Finlay J C and Hahn S M 2005b determination of the distribution of light, optical properties, drug concentration, and tissue oxygenation in-vivo in human prostate during motexafin lutetium-mediated photodynamic Therapy J. Photochem. Photobiol. B: Biol. 79 231-41
26. Zhu T C, Hahn S M, Kapatkin A S, Dimofte A, Rodriguez C E, Vulcan T G, Glatstein E and His R A 2003 In vivo Optical properties of normal canine prostate at 732 nm using motexafin lutetium-mediated photodynamic therapy Photochem. Photobiol. 77 81-8